These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 7684597

  • 1. Prognostic implications of tumour marker analysis in non-seminomatous germ cell tumours with poor prognosis metastatic disease.
    Gerl A, Clemm C, Lamerz R, Mann K, Wilmanns W.
    Eur J Cancer; 1993; 29A(7):961-5. PubMed ID: 7684597
    [Abstract] [Full Text] [Related]

  • 2. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
    Fizazi K, Pagliaro L, Laplanche A, Fléchon A, Mardiak J, Geoffrois L, Kerbrat P, Chevreau C, Delva R, Rolland F, Theodore C, Roubaud G, Gravis G, Eymard JC, Malhaire JP, Linassier C, Habibian M, Martin AL, Journeau F, Reckova M, Logothetis C, Culine S.
    Lancet Oncol; 2014 Dec; 15(13):1442-1450. PubMed ID: 25456363
    [Abstract] [Full Text] [Related]

  • 3. Serum lactate dehydrogenase isoenzyme 1 and tumour volume are indicators of response to treatment and predictors of prognosis in metastatic testicular germ cell tumours.
    von Eyben FE, Blaabjerg O, Madsen EL, Petersen PH, Smith-Sivertsen C, Gullberg B.
    Eur J Cancer; 1992 Dec; 28(2-3):410-5. PubMed ID: 1375486
    [Abstract] [Full Text] [Related]

  • 4. Serum lactate dehydrogenase isoenzyme 1 and prediction of death in patients with metastatic testicular germ cell tumors.
    von Eyben FE, Blaabjerg O, Hyltoft-Petersen P, Madsen EL, Amato R, Liu F, Fritsche H.
    Clin Chem Lab Med; 2001 Jan; 39(1):38-44. PubMed ID: 11256799
    [Abstract] [Full Text] [Related]

  • 5. Tumour markers in testicular germ cell tumours. Five-year experience from the DATECA Study 1976-1980.
    Nørgaard-Pedersen B, Schultz HP, Arends J, Brincker H, Krag Jacobsen G, Lindeløv B, Rørth M, Svennekjaer IL.
    Acta Radiol Oncol; 1984 Jan; 23(4):287-94. PubMed ID: 6208749
    [Abstract] [Full Text] [Related]

  • 6. Tumour marker concentration at the start of chemotherapy is a stronger predictor of treatment failure than marker half-life: a study in patients with disseminated non-seminomatous testicular cancer.
    de Wit R, Sylvester R, Tsitsa C, de Mulder PH, Sleyfer DT, ten Bokkel Huinink WW, Kaye SB, van Oosterom AT, Boven E, Vermeylen K, Stoter G.
    Br J Cancer; 1997 Jan; 75(3):432-5. PubMed ID: 9020492
    [Abstract] [Full Text] [Related]

  • 7. Prognostic factors in advanced non-seminomatous germ-cell testicular tumours: results of a multicentre study. Report from the Medical Research Council Working Party on Testicular Tumours.
    Lancet; 1985 Jan 05; 1(8419):8-11. PubMed ID: 2578205
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Serum estradiol as a tumour marker for non-seminomatous germinal cell tumours (NSGCT) of the testis.
    Uysal Z, Bakkaloğlu M.
    Int Urol Nephrol; 1987 Jan 05; 19(4):415-8. PubMed ID: 2448261
    [Abstract] [Full Text] [Related]

  • 13. Prognostic significance of marker half-life during chemotherapy in non-seminomatous germ cell testicular tumors.
    Inanç SE, Meral R, Darendeliler E, Yasasever V, Onat H.
    Acta Oncol; 1999 Jan 05; 38(4):505-9. PubMed ID: 10418719
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Germ cell tumours of testis: prognostic factors and results.
    Nikzas D, Champion AE, Fox M.
    Eur Urol; 1990 Jan 05; 18(4):242-7. PubMed ID: 1705226
    [Abstract] [Full Text] [Related]

  • 19. Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers.
    Habuchi T, Kamoto T, Hara I, Kawai K, Nakao M, Nonomura N, Kobayashi T, Ogawa O, Kamidono S, Akaza H, Okuyama A, Kato T, Miki T.
    Cancer; 2003 Oct 15; 98(8):1635-42. PubMed ID: 14534879
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.